Justin Sturge, Matthew P . Caley and Jonathan Waxman Nat. Rev. Clin. Oncol. 8, 357-368 (2011); doi:10.1038 /nrclinonc.2011 In the version of this article initially published online the title of Table 1 should have read "Completed and ongoing trials with bisphosphonates" and it should have stated that trial NCT00330759 excluded patients with prostate cancer. In Table 2 , it should have been defined that patients enrolled in trial NCT00089674 did not present with any type of metastases and that the secondary end point was fractures. It should have also stated that trial NCT00321620 assessed denosumab versus zoledronic acid. The errors have been corrected for the HTML and PDF versions of the article.
